Ellevest Inc’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,334
Closed -$172K 1672
2023
Q1
$172K Buy
1,334
+95
+8% +$11.9K 0.01% 342
2022
Q4
$158K Buy
1,239
+103
+9% +$12K 0.01% 342
2022
Q3
$119K Sell
1,136
-761
-40% -$83.5K 0.01% 380
2022
Q2
$199K Buy
1,897
+587
+45% +$69.6K 0.02% 279
2022
Q1
$168K Buy
1,310
+511
+64% +$61.6K 0.01% 338
2021
Q4
$99K Buy
799
+730
+1,058% +$95.5K 0.01% 389
2021
Q3
$10K Sell
69
-5
-7% -$736 ﹤0.01% 826
2021
Q2
$12K Sell
74
-61
-45% -$9.88K ﹤0.01% 734
2021
Q1
$21K Sell
135
-945
-88% -$146K ﹤0.01% 649
2020
Q4
$162K Buy
1,080
+135
+14% +$19.1K 0.02% 202
2020
Q3
$125K Buy
945
+291
+44% +$38K 0.02% 199
2020
Q2
$76K Buy
654
+309
+90% +$35.6K 0.02% 283
2020
Q1
$34K Buy
345
+265
+331% +$34.7K 0.01% 314
2019
Q4
$12K Buy
80
+78
+3,900% +$10.8K ﹤0.01% 511
2019
Q3
$0 Buy
+2
New +$258 ﹤0.01% 622

Other funds holding ZBH

Ellevest Inc's ZBH Position: Q2 2023 in Review

Ellevest Inc sold out of Zimmer Biomet (ZBH) in Q2 2023, closing a stake of 1,334 shares — an estimated $172K sold.

Ellevest Inc first reported a position in ZBH in Q3 2019 and held it in 15 quarters. The position peaked at $199K in Q2 2022. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

  • Ellevest Inc reported no remaining Zimmer Biomet position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 1,334 Zimmer Biomet shares in Q2 2023, an estimated $172K.
  • Ellevest Inc first reported a position in Zimmer Biomet in Q3 2019 and held it in 15 quarters.
  • Ellevest Inc's Zimmer Biomet position peaked at $199K in Q2 2022.
  • 1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.